Европейски съюз - фински - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - obstruktiivisten hengitystiesairauksien lääkkeet, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Европейски съюз - фински - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - obstruktiivisten hengitystiesairauksien lääkkeet, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Финландия - фински - Fimea (Suomen lääkevirasto)

sanofi oy - trimipramine maleate - tabletti, kalvopäällysteinen - 25 mg - trimipramiini

Финландия - фински - Fimea (Suomen lääkevirasto)

glaxosmithkline (ireland) limited - salbutamol sulfate - sumutinliuos - 5 mg/ml - salbutamoli

Финландия - фински - Fimea (Suomen lääkevirasto)

glaxosmithkline oy - salbutamol sulfate - sumutinliuos - 1 mg/ml - salbutamoli

Финландия - фински - Fimea (Suomen lääkevirasto)

glaxosmithkline oy - salbutamol sulfate - sumutinliuos - 2 mg/ml - salbutamoli

Финландия - фински - Fimea (Suomen lääkevirasto)

astrazeneca oy - formoterol fumarate dihydrate - inhalaatiojauhe - 6 mikrog/annos - formoteroli

Финландия - фински - Fimea (Suomen lääkevirasto)

astrazeneca oy - formoterol fumarate dihydrate - inhalaatiojauhe - 12 mikrog/annos - formoteroli

Финландия - фински - Fimea (Suomen lääkevirasto)

astrazeneca oy - budesonide, formoterol fumarate dihydrate - inhalaatiojauhe - formoteroli ja budesonidi

Финландия - фински - Fimea (Suomen lääkevirasto)

astrazeneca oy - budesonide, formoterol fumarate dihydrate - inhalaatiojauhe - formoteroli ja budesonidi